Combined Hormonal Contraceptives Market

Combined hormonal contraceptives are used to prevent pregnancies. They are also used in the treatment of acne vulgaris, endometriosis, polycystic ovarian syndrome, and irregular menstrual flow by blocking ovulation. These products are widely used by women of aged between 15 and 49 years.
Combined Hormonal Contraceptives Market contains market size and forecasts of Combined Hormonal Contraceptives in global, including the following market information:
Global Combined Hormonal Contraceptives Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Combined Hormonal Contraceptives Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Combined Hormonal Contraceptives companies in 2021 (%)
The global Combined Hormonal Contraceptives market was valued at 18300 million in 2021 and is projected to reach US$ 22730 million by 2028, at a CAGR of 3.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
15-24 years Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Combined Hormonal Contraceptives include Actavis, Agile Therapeutics, Allergan, Bayer, Teva Pharmaceutical Industries, ANI Pharmaceuticals, Ortho-McNeil-Janssen Pharmaceuticals, Noven Pharmaceuticals and Johnson & Johnson and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Combined Hormonal Contraceptives manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Combined Hormonal Contraceptives Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Combined Hormonal Contraceptives Market Segment Percentages, by Type, 2021 (%)
15-24 years
25-34 years
35-44 years
Above 44 years
Global Combined Hormonal Contraceptives Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Combined Hormonal Contraceptives Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Global Combined Hormonal Contraceptives Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Combined Hormonal Contraceptives Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Combined Hormonal Contraceptives revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Combined Hormonal Contraceptives revenues share in global market, 2021 (%)
Key companies Combined Hormonal Contraceptives sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Combined Hormonal Contraceptives sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Actavis
Agile Therapeutics
Allergan
Bayer
Teva Pharmaceutical Industries
ANI Pharmaceuticals
Ortho-McNeil-Janssen Pharmaceuticals
Noven Pharmaceuticals
Johnson & Johnson
Mylan